{"id":"W2890158093","doi":"10.1200/jco.2017.35.15_suppl.tps2613","title":"A phase I study of oral SRA737 (formerly CCT245737) given in combination with gemcitabine plus cisplatin or gemcitabine alone in patients with advanced cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"","keywords":"Gemcitabine; Cisplatin; Medicine; CHEK1; Cancer; Cancer research; DNA damage; Oncology; Cell cycle; Chemotherapy; Cell cycle checkpoint; Internal medicine; Pharmacology; DNA; Biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001005651,0.002252384,0.00284421,0.0008368483,0.0006663206,0.001163926,0.001338536,0.001509286,0.006280616],"category_scores_gemma":[0.0007459742,0.000847836,0.001579674,0.0007428922,0.001217214,0.001071238,0.0004274109,0.003912838,0.001598465],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001349867,"about_ca_system_score_gemma":0.003207721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002666292,"about_ca_topic_score_gemma":0.005521868,"domain_scores_codex":[0.9995416,0.0001792825,0.00001982664,0.00008759274,0.00004726072,0.000124466],"domain_scores_gemma":[0.9991943,0.00008088356,0.0001260509,0.00006720733,0.00005131231,0.0004802077],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6363578,0.1707076,0.004576127,0.001234702,0.001375177,0.0005140484,0.0003629464,0.003815527,0.06590143,0.0005330165,0.007265971,0.1073557],"study_design_scores_gemma":[0.3189173,0.6683678,0.005388508,0.00002924235,0.0003473297,0.0002620976,0.00007398784,0.0008542371,0.003218408,0.0001573522,0.002349541,0.00003415857],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860317,0.001647982,0.0005668664,0.0005433958,0.0002130602,0.006121058,0.001538911,0.0001824421,0.003154545],"genre_scores_gemma":[0.9815177,0.002561055,0.002019193,0.000992695,0.0002634585,0.005156287,0.003393141,0.00006016467,0.004036258],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006280616,"threshold_uncertainty_score":0.02101082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04717677595504453,"score_gpt":0.4254148122645905,"score_spread":0.378238036309546,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}